Industry & Policy News

[Akeso Inc. ] Akeso, Inc. announced the completion of patient enrollment for its Phase III registrational clinical trial evaluating cadonilimab as an adjuvant treatment for HCC with high recurrence risk following curative resection or ablation.

[Nachrichten Informationsdienst Wissenschaft] The National Strategy for gene and cell-based therapies funds the University Hospital Regensburg and the Leibniz Institute for immunotherapy to advance cutting-edge T cell therapy for sarcoma patients.

[University of Barcelona] The Association Against Cancer presented the 49 AECC 2024 grants of which three grants have been awarded to researchers at the University of Barcelona.

[Advanced Science News] Dr. Claudia Loebel is this year’s recipient of Macromolecular Rapid Communications Junior Researcher Award. She and her research group use spongy, water-soluble polymers called hydrogels to recreate the ECM of specific organs, like the lung, in the lab.

[FibroBiologics, Inc.] FibroBiologics, Inc. announced the filing of a patent application with the United States Patent and Trademark Office covering methods employing fibroblasts to improve mitochondrial performance in cells.

[uBriGene (BioSpace)] uBriGene Biosciences (uBriGene) announced the submission of its Drug Master File for its innovative iPSC Reprogramming mRNA-LNP Kit. This comprehensive regulatory submission details the manufacturing and characterizations of the iPSC Reprogramming mRNA-LNP Kit.